UNICA IRIS Institutional Research Information System

CASTELLI, MARIA PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 134.018
NA - Nord America 9.121
AS - Asia 2.967
SA - Sud America 435
Continente sconosciuto - Info sul continente non disponibili 326
AF - Africa 88
OC - Oceania 13
Totale 146.968
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 130.373
US - Stati Uniti d'America 8.912
NL - Olanda 1.900
SG - Singapore 1.205
CN - Cina 995
SE - Svezia 419
UA - Ucraina 376
BR - Brasile 327
VN - Vietnam 236
DE - Germania 220
GB - Regno Unito 214
FI - Finlandia 168
FR - Francia 140
CA - Canada 124
HK - Hong Kong 109
IN - India 90
KR - Corea 57
BD - Bangladesh 52
AR - Argentina 39
JP - Giappone 39
PL - Polonia 39
RU - Federazione Russa 34
IQ - Iraq 23
AT - Austria 20
BE - Belgio 20
ES - Italia 20
ZA - Sudafrica 20
ID - Indonesia 19
MX - Messico 19
TR - Turchia 19
MA - Marocco 17
UZ - Uzbekistan 16
CZ - Repubblica Ceca 14
EC - Ecuador 14
PH - Filippine 14
SA - Arabia Saudita 14
CL - Cile 13
IL - Israele 13
CO - Colombia 12
VE - Venezuela 12
IE - Irlanda 11
AU - Australia 10
CR - Costa Rica 10
PK - Pakistan 10
TN - Tunisia 10
KE - Kenya 9
MY - Malesia 9
SC - Seychelles 9
CH - Svizzera 8
GT - Guatemala 8
JM - Giamaica 8
PE - Perù 8
TT - Trinidad e Tobago 8
EG - Egitto 7
PR - Porto Rico 7
EU - Europa 6
HN - Honduras 6
CW - ???statistics.table.value.countryCode.CW??? 5
IR - Iran 5
JO - Giordania 5
NO - Norvegia 5
PY - Paraguay 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
EE - Estonia 4
ET - Etiopia 4
PT - Portogallo 4
RO - Romania 4
RS - Serbia 4
SN - Senegal 4
SV - El Salvador 4
AZ - Azerbaigian 3
GE - Georgia 3
GR - Grecia 3
LV - Lettonia 3
NI - Nicaragua 3
NP - Nepal 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
AM - Armenia 2
BB - Barbados 2
BO - Bolivia 2
DZ - Algeria 2
GF - Guiana Francese 2
GP - Guadalupe 2
HR - Croazia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
MU - Mauritius 2
NG - Nigeria 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BS - Bahamas 1
Totale 146.641
Salva come PNG Salva come JPEG
Città #
Cagliari 127.302
Uta 2.670
Amsterdam 1.871
Ashburn 1.016
Fairfield 612
Singapore 608
Dallas 605
San Jose 544
Woodbridge 481
Houston 417
Chandler 416
Boardman 277
Ann Arbor 269
Seattle 239
Wilmington 236
Nyköping 231
Jacksonville 206
Cambridge 202
Beijing 188
Los Angeles 153
Council Bluffs 152
Dearborn 136
Santa Clara 128
New York 126
The Dalles 103
Helsinki 101
Hong Kong 96
Shanghai 86
Hefei 82
Ho Chi Minh City 74
Lauterbourg 71
Boston 69
Nanjing 63
Munich 62
Seoul 57
Hanoi 51
Buffalo 46
San Francisco 41
San Diego 40
Orem 38
Atlanta 37
Denver 37
Brooklyn 34
Chicago 33
Columbus 33
Toronto 32
Nanchang 31
São Paulo 31
Tokyo 31
Montreal 30
Dong Ket 29
Frankfurt am Main 29
London 29
Milan 29
Warsaw 28
Washington 28
Phoenix 27
Rome 27
Hebei 25
Shenyang 23
Tianjin 23
Mountain View 22
Redwood City 22
Guangzhou 20
Princeton 19
Changsha 18
Chennai 18
Stockholm 18
Verona 18
Sassari 17
Brussels 16
Jiaxing 16
Jinan 15
Norwalk 15
Redondo Beach 15
Nuremberg 14
Tashkent 14
Johannesburg 13
Philadelphia 13
Vienna 13
Falls Church 12
Haiphong 11
Hangzhou 11
Wuhan 11
Baghdad 10
Auburn Hills 9
Casablanca 9
Dhaka 9
Dublin 9
Paris 9
Pittsburgh 9
Victoria 9
Detroit 8
North Bergen 8
Orange 8
San José 8
Tampa 8
Brasília 7
Brno 7
Buenos Aires 7
Totale 141.286
Salva come PNG Salva come JPEG
Nome #
α2A adrenergic receptors highly expressed in mesoprefrontal dopamine neurons 5.833
Reversible disruption of pre-pulse inhibition in hypomorphic-inducible and reversible CB1-/- mice 5.260
PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. 5.171
Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in sardinian alcohol-preferring rats 4.202
Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135 4.173
Δ9-Tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity 3.926
Regional distribution of 5α-reductase type 2 in the adult rat brain: An immunohistochemical analysis 3.582
Male and Female Rats Differ in Brain Cannabinoid CB1 Receptor Density and Function and in Behavioural Traits Predisposing To Drug Addiction: Effect of Ovarian Hormones. 3.251
The agression and behavioral abnormalities associated with monoamine oxidase A deficiency are rescued by acute inhibition of serotonin reuptake. 3.202
Limited access to a high fat diet alters endocannabinoid tone in female rats 3.119
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence. 2.977
Cannabinoid CB1 receptors in the paraventricular nucleus and central control of penilemerection: immunohistochemistry,autoradiography and behavvioral studies 2.806
Inhibition of steroid 5-alpha reductase reduces marble-burying responses in mice 2.731
Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent 2.696
NMDARs mediate the role of monoamine oxidase A in pathological aggression 2.640
Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells 2.630
Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa 2.622
Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a G alpha(i/o) protein inhibitor 2.587
Suppressing effect of saikosaponin A, an active ingredient of Bupleurum falcatum, on chocolate self-administration and reinstatement of chocolate seeking in rats 2.531
In vitro and in vivo pharmacological characterization of SSD114, a novel GABAB positive allosteric modulator 2.498
The new compound GET73, N-[(4-trifluoromethyl)benzyl]4-methoxybutyramide, regulates hippocampal aminoacidergic transmission possibly via an allosteric modulation of mGlu5 receptor. Behavioural evidence of its "anti-alcohol" and anxiolytic properties. 2.424
Methamphetamine induces long-term alterations in reactivity to environmental stimuli: correlation with dopaminergic and serotoninergic toxicity 2.407
Cannabis and the Use of Amphetamine-Like Substances 2.391
The cannabinoid receptor antagonist SR-141716A induces penile erection in male rats: Involvement of paraventricular glutamic acid and nitric oxide 2.374
In vitro functional characterization of GET73 as possible negative allosteric modulator of metabotropic glutamate receptor 5 2.283
Activation of GABA(B) receptors reverses spontaneous gating deficits in juvenile DBA/2J mice 2.167
NMDA receptors mediate the role of monoamine oxidase A in pathological aggression 2.144
Characterization of COR627 and COR628, Two Novel Positive Allosteric Modulators of the GABAB Receptor. 2.125
Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB(1) cannabinoid receptors 2.097
null 2.010
Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe 1.967
Distribution and localization of the GABAB receptor 1.962
6-Hydroxydopamine lesion in the ventral tegmental area fails to reduce extracellular dopamine in the cerebral cortex 1.952
Persistent increase in CB1 receptor and amnestic effect of cannabinoid by methamphetamine 1.934
null 1.888
Cannabinoid CB1 receptors in the paraventricular nucleus and central control of penile erection: immunocytochemistry, autoradiography and behavioural studies 1.859
(-) S amisulpride binds with high affinity to cloned dopamine D3 and D2 receptors 1.852
Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2 1.828
Localization of steroid 5α-reductase type 2 isozyme in the adult rat brain 1.755
Anti-Alcohol and Anxiolytic Properties of a New Chemical Entity, GET73. 1.723
Differential G-protein coupling to GABAB receptor in limbic areas of alcohol-preferring and -nonpreferring rats 1.701
A review of pharmacology of NCS-382, a putative antagonist of gamma-hydroxybutyric acid (GHB) receptor 1.547
Midbrain 6-OHDA lesion fails to reduce extracellular dopamine in cerebral cortex. 1.491
Structure optimization of positive allosteric modulators of GABAB receptors led to the unexpected discovery of antagonists/potential negative allosteric modulators 1.415
Adolescent exposure to nicotine and/or the cannabinoid agonist CP 55,940 induces gender-dependent long lasting memory impairments and changes in brain nicotinic and CB1 cannabinoid receptors 1.405
Sex and gender differences in the effects of novel psychoactive substances 1.393
Changes induced by acute toxic dose (ATD) of methanphetamine (METH) on cannabinoid CB1 receptors: An immunocytochemistry study 1.300
COR758, a negative allosteric modulator of GABAB receptors 1.173
Methamphetamine-induced damages of serotoninergic and dopaminergic terminals are not paralleled by overt mnemonic and pre-attentional alterations 1.156
The GABAB receptor positive allosteric modulator COR659: in vitro metabolism, in vivo pharmacokinetics in rats, synthesis and pharmacological characterization of metabolically protected derivatives 1.140
Human neuronal cell lines as an in vitro toxicological tool for the evaluation of novel psychoactive substances 1.074
Multi-faceted aspects of gamma-hydroxybutyric acid: a neurotransmitter, therapeutic agent and drug of abuse 1.067
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 1.058
Predisposition to alcohol drinking and alcohol consumption alter expression of calcitonin gene-related peptide, neuropeptide Y, and microglia in bed nucleus of stria terminalis in a subnucleus-specific manner 1.009
Chronic morphine and naltrexone fail to modify µ-opioid receptor mRNA levels in the rat brain 959
Up-regulation of GABA(B) receptors by chronic administration of the GABA(B) receptor antagonist SCH 50,911 877
Design, synthesis, and biological evaluation of new 1,8-naphthyridin-4(1H)-on-3-carboxamide and quinolin-4(1H)-on-3-carboxamide derivatives as CB2 selective agonists 874
Distribution of GABA B receptor mRNAs in the rat brain and peripheral organs 792
Stereoselectivity of NCS-382 binding to gamma-hydroxybutyrate (GHB) receptor in the rat brain 773
Pharmacological characterization of novel synthetic opioids: Isotonitazene, metonitazene, and piperidylthiambutene as potent μ-opioid receptor agonists 743
Selective gamma-hydroxybutyric acid receptor ligands increase extracellular glutamate in hippocampus, but fail to activate G protein and to produce the sedative/hypnotic effect of gamma-hydroxybutyric acid 727
Adolescent self-administration of the synthetic cannabinoid receptor agonist JWH-018 induces neurobiological and behavioral alterations in adult male mice 714
Reconstitution of the human 5-HT(1D) receptor-G-protein coupling: evidence for constitutive activity and multiple receptor conformations 676
Thyroid transcription factor 1 activates the promoter of the tyrothropin receptor gene 671
Central effects of 1,4-butanediol are mediated by GABAB receptors via its conversion into gamma-hydroxybutyric acid 664
Continuous subcutaneous insulin infusion (CSII) in pregnant diabetic patients 661
Immune and glial cell alterations in the rat brain after repeated exposure to the synthetic cannabinoid JWH-018 653
3‐[3‐(Phenalkylamino)cyclohexyl]phenols: Synthesis, biological activity, and in silico investigation of a naltrexone‐derived novel class of MOR‐antagonists 647
Quantitative autoradiographic distribution of gamma-hydroxybutyric acid binding sites in human and monkey brain 638
CATHEPSIN-G INDUCED RELEASE OF PAI-1 IN THE CULTURE-MEDIUM OF ENDOTHELIAL-CELLS - A NEW THROMBOGENIC ROLE FOR POLYMORPHONUCLEAR LEUKOCYTES 616
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring 596
Synthesis and pharmacological characterization of 2-(acylamino)thiophene derivatives as metabolically stable, orally effective, positive allosteric modulators of the GABAB receptor 590
Molecular pharmacology of the Beta-adrenergic receptor on THP-1 cells 588
Recombinant cytokines IL-2, IL-1, IFN-G, G-CSF and GM-CSF augment CFU-C activity in normal, cyclophosphamide-treated or irradiated mice as well as reduce the lethality of these myelotoxic agents 579
Protective, restorative, and therapeutic properties of recombinant colony-stimulating factors 565
Functional and surface phenotype study of lymphocyte subsets in peripheral blood and lymph nodes of breast cancer patients 562
Synthesis, structural properties, and pharmacological evaluation of 2-(acylamino)-thiophene-3-carboxamides and analogues thereof 554
Effects of Antiestrogen and Progestin on Immune Functions in Breast Cancer Patients 520
Regioselective synthesis of new EWG-Bearing 3-benzoyl-2-phenylbenzofurans by one-pot intramolecular acylation/thermal cyclization of phosphoranes and their CB1 antagonist activity 511
Correlations between Gustatory, Olfactory, Cognitive Function, and Age in Healthy Women 469
null 448
Dopamine D3 receptor antisense oligodeoxynucleotide potentiates imipramine-induced dopaminergic behavioural supersensitivity 313
Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination 310
null 281
Food restriction and hyperactivity induce changes in corticolimbic brain dopamine and serotonin levels in female rats 242
Protective, restorative, and therapeutic properties of recombinant human IL-1 in rodent models. 237
Correction to: Adolescent self‑administration of the synthetic cannabinoid receptor agonist JWH‑018 induces neurobiological and behavioral alterations in adult male mice 192
The novel synthesized naltrexone-related MOR antagonist AT-99 counteracts dopamine releasing and behavioral depressant morphine-induced effects 126
Maternal immune activation with high molecular weight poly (I:C) induces selective depressive-like phenotype in adult offspring 54
null 24
The PPARα agonist fenofibrate reduces the cytokine imbalance in a maternal immune activation model of schizophrenia 14
Totale 146.968
Salva come PNG Salva come JPEG
Categoria #
all - tutte 188.417
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 188.417
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.682 0 0 0 0 637 731 503 406 488 724 1.197 996
2022/202311.794 1.081 1.320 1.207 976 906 1.542 559 834 821 866 1.130 552
2023/202411.633 608 476 452 640 1.130 1.776 1.899 760 667 786 1.221 1.218
2024/202517.382 3.469 4.091 2.513 2.375 1.338 1.280 1.225 146 280 185 239 241
2025/20268.692 488 336 919 459 490 410 1.313 568 2.249 871 370 219
2026/20272.802 533 1.023 469 667 110 0 0 0 0 0 0 0
Totale 146.968